Literature DB >> 16046412

Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans.

Veronique Vreys1, Nathalie Delande, Zhe Zhang, Christien Coomans, Anton Roebroek, Joachim Dürr, Guido David.   

Abstract

Mammalian heparanase, strongly implicated in the regulation of cell growth, migration, and differentiation, plays a crucial role in inflammation, angiogenesis, and metastasis. There is thus a clear need for understanding how heparanase activity is regulated. Cells can generate an active form of the enzyme from a larger inactive precursor protein by a process of secretion-recapture, internalization, and proteolytic processing in late endosomes/lysosomes. Cell surface heparan sulfate proteoglycans are the sole known components with a role in this trafficking of the heparanase precursor. Here, we provide evidence that heparan sulfate proteoglycans are not strictly required for this process. More importantly, by heparanase transfection, binding, and uptake experiments and by using a combination of specific inhibitors and receptor-defective cells, we have identified low density lipoprotein receptor-related proteins and mannose 6-phosphate receptors as key elements of the receptor system that mediates the capture of secreted heparanase precursor and its trafficking to the intracellular site of processing/activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046412     DOI: 10.1074/jbc.M503007200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.

Authors:  Anurag Purushothaman; Douglas R Hurst; Claudio Pisano; Shuji Mizumoto; Kazuyuki Sugahara; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

2.  Heparanase in health and disease: The neglected housekeeper of the cell?

Authors:  Jun Shu; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2019-01-25       Impact factor: 5.162

3.  Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.

Authors:  Camilla A Thompson; Anurag Purushothaman; Vishnu C Ramani; Israel Vlodavsky; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

4.  Characterization of heparanase-induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence.

Authors:  Anjum Riaz; Neta Ilan; Israel Vlodavsky; Jin-Ping Li; Staffan Johansson
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

5.  Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.

Authors:  Vishnu C Ramani; Israel Vlodavsky; Mary Ng; Yi Zhang; Paola Barbieri; Alessandro Noseda; Ralph D Sanderson
Journal:  Matrix Biol       Date:  2016-03-22       Impact factor: 11.583

Review 6.  The glycocalyx--linking albuminuria with renal and cardiovascular disease.

Authors:  Ton J Rabelink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2015-10-13       Impact factor: 28.314

7.  Low and high affinity receptors mediate cellular uptake of heparanase.

Authors:  Olga Ben-Zaken; Itay Shafat; Svetlana Gingis-Velitski; Haim Bangio; Idil Kasuto Kelson; Tal Alergand; Yehudit Amor; Ruth Ben-Yakar Maya; Israel Vlodavsky; Neta Ilan
Journal:  Int J Biochem Cell Biol       Date:  2007-09-29       Impact factor: 5.085

8.  Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.

Authors:  Anurag Purushothaman; Ligong Chen; Yang Yang; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

9.  Clinical significance of urine heparanase in bladder cancer progression.

Authors:  Itay Shafat; Dov Pode; Tamar Peretz; Neta Ilan; Israel Vlodavsky; Benjamin Nisman
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

10.  Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

Authors:  Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.